Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|May 3, 2011
Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapyM Joerger, D deJong, A Burylo, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2015
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)M Joerger, R H N van Schaik, M L Becker, et al.
ESMO Open|October 2, 2022
How to read a next-generation sequencing report-what oncologists need to knowS Schmid, W Jochum, B Padberg, et al.
Cancer Chemotherapy and Pharmacology|October 30, 2013
Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunctionM Joerger, A D R Huitema, D Koeberle, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based studyP Neumair, L Joos, R Warschkow, et al.
British Journal of Cancer|February 4, 2010
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trialM Joerger, A D R Huitema, S Krähenbühl, et al.
Cell Death and Differentiation|May 16, 2015
PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signalingM Mueller, A Schoeberlein, J Zhou, et al.
British Journal of Clinical Pharmacology|July 18, 2006
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patientsM Joerger, A D R Huitema, H J G D van den Bongard, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2023
SAKK57/16 Nab-paclitaxel and Gemcitabine in Soft Tissue Sarcoma (NAPAGE): a phase I/II trialA Digklia, A Kollár, D Dietrich, et al.
ESMO Open|March 29, 2023
Implementation of dihydropyrimidine dehydrogenase deficiency testing in EuropeM de With, A Sadlon, E Cecchin, et al.
Pageof 5